Trial document

drksid header

DRKS-ID: DRKS00006234

Trial Description

start of 1:1-Block title

Title

Aortic plaques as a source of stroke - MRI based morphological and functional analysis of the aorta.

end of 1:1-Block title

start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym

start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url

start of 1:1-Block public summary

Brief Summary in Lay Language

Aortic atheroma are known to be a relevant source of stroke for 20 years. However, it is unclear why they occur in specific areas of the aorta, which hemodynamic parameters have influence on their formation and progression, and if plaques of the descending aorta cause brain infarction due to diastolic blood flow reversal. This project aims to apply Magnetic Resonance Imaging (MRI) for detection and evaluation of aortic atheroma in 3D. Furthermore, functional MRI will be performed to visualize individual blood flow and evaluate the risk of embolization to the brain. All experiments will be performed on stroke patients and controls.

end of 1:1-Block public summary

start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Aortic plaques are known to be a relevant source of stroke for 20 years. However, it is unclear why they occur on predilection sites, which hemodynamic parameters have influence on their formation, progression, and rupture, and if plaques of the descending aorta cause brain infarction due to diastolic blood flow reversal. This projects aims to apply the combination of functional MRI with modern image analysis methods for the evaluation of the risk of infarction due to plaques of the descending aorta on a representative cohort of stroke patients and controls. Atheroma of the aorta are detected and characterized concerning their composition by using a multi-parametric 3D/4D MRI protocol. Subsequently, the location of plaques can be correlated with local wall shear stress and elasticity of the aorta, which are acquired quantitatively by 4D flow MRI. It should be determined to what extend altered local hemodynamics are a predictor for the occurrence and rupture of vulnerable plaques. Furthermore, individual embolization pathways can be visualized and the connection between aortic atheroma and the location of cerebral infarction should be quantified using connectivity maps. Thus, the relevance of the so far neglected but numerous plaques of the descending aorta as a high-risk source of stroke can be evaluated resulting in an optimized secondary prevention in the future.

end of 1:1-Block scientific synopsis

start of 1:1-Block organizational data

Organizational Data

DRKS-ID: DRKS00006234
Date of Registration in DRKS: 2014/06/11
Date of Registration in Partner Registry or other Primary Registry: [---]*
Investigator Sponsored/Initiated Trial (IST/IIT): yes
Ethics Approval/Approval of the Ethics Committee: Approved
(leading) Ethics Committee No.: 227/14, Ethik-Kommission der Albert-Ludwigs-Universität Freiburg

end of 1:1-Block organizational data

start of 1:n-Block secondary IDs

Secondary IDs

Universal Trial Number (UTN): U1111-1157-8605

end of 1:n-Block secondary IDs

start of 1:N-Block indications

Health Condition or Problem studied

ICD10: I63 - Cerebral infarction

end of 1:N-Block indications

start of 1:N-Block interventions

Interventions/Observational Groups

Arm 1: Stroke patients undergo aortic MRI (3D multicontrast MRI and 4D flow MRI) for the detection and evaluation of atherosclerotic plaques and analysis of blood flow.
Arm 2: Ophthalmic patients (controls) undergo aortic MRI (3D multicontrast MRI and 4D flow MRI) for the detection and evaluation of atherosclerotic plaques and analysis of blood flow.

end of 1:N-Block interventions

start of 1:1-Block design

Characteristics

Study Type: Non-interventional
Study Type Non-Interventional: Other
Allocation: Non-randomized controlled trial
Blinding: Open (masking not used)
Who is blinded: [---]*
Control: Other
Purpose: Diagnostic
Assignment: Other
Phase: N/A
Off-label Drug use: N/A

end of 1:1-Block design

start of 1:1-Block primary endpoint

Primary Outcome

Quantitative analysis of the frequency of retrograde embolization from complex plaques of the descending aorta into the supra-aortic arteries in patients with undetermined and determined stroke etiology and controls.

end of 1:1-Block primary endpoint

start of 1:1-Block secondary endpoint

Secondary Outcome

1. Quantification of plaque morphology using 3D multicontrast MRI. 2. In stroke patients: Testing the hypothesis that plaques occur primarily on locations with critically altered WSS and reduced PWV. 3. Correlation of aortic elasticity and flow reversal in the descending aorta.

end of 1:1-Block secondary endpoint

start of 1:n-Block recruitment countries

Countries of Recruitment

DE: Germany

end of 1:n-Block recruitment countries

start of 1:n-Block recruitment locations

Locations of Recruitment

University Medical Center Universitätskliniken für Neurologie und Augenheilkunde, Freiburg im Breisgau

end of 1:n-Block recruitment locations

start of 1:1-Block recruitment

Recruitment

Planned/Actual: Actual
(Anticipated or Actual) Date of First Enrollment: 2014/09/25
Target Sample Size: 100
Monocenter/Multicenter trial: Monocenter trial
National/International: National

end of 1:1-Block recruitment

start of 1:1-Block inclusion criteria

Inclusion Criteria

Gender: Both, male and female
Minimum Age: 50 Years
Maximum Age: no maximum age

end of 1:1-Block inclusion criteria

start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

1. Stroke patients: male and female, >49 years of age, acute stroke, cryptogenic stroke etiology after routine diagnostics (without TEE), visible ischemic lesion on cerebral imaging. 2. Control patients: male and female, >49 years of age, no history of cerebral or retianl ischemia.

end of 1:1-Block inclusion criteria add

start of 1:1-Block exclusion criteria

Exclusion Criteria

Contraindications for MRI (ferromagentic prosthesis, cardiac pacemaker, implantable cardioverter defibrillator, insulin pump, large-scale tattoos with metalliferous pigment, artificial heart valves, pregnancy, chochlea implant, copper-bearing contraceptive coil, non-removable piercings, shell splinters or other metallic material), cardiac arrhythmias, bad general condition, no informed consent obtainable, strong claustrophobia, body weight over 130kg, refusal to participate in the study

end of 1:1-Block exclusion criteria

start of 1:n-Block addresses

Addresses

Primary Sponsor
start of 1:1-Block address primary-sponsor
- Universitätsklinikum Freiburg Abteilung Neurologie und Neurophysiologie
- Mr. Prof. Dr. Andreas Harloff
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address primary-sponsor

start of 1:1-Block address contact primary-sponsor
- Telephone: ++49-0761 270-50010
- Fax: [---]*
- E-mail: andreas.harloff at uniklinik-freiburg.de
- URL: http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact primary-sponsor
Collaborator, Other Address
start of 1:1-Block address other
- Universitätsklinikum Freiburg Abteilung Augenheilkunde
- Killianstraße 5
- 79106 Freiburg
- Germany
end of 1:1-Block address other

start of 1:1-Block address contact other
- Telephone: [---]*
- Fax: [---]*
- E-mail: [---]*
- URL: [---]*
end of 1:1-Block address contact other
Contact for Scientific Queries
start of 1:1-Block address scientific-contact
- Universitätsklinikum Freiburg Abteilung Neurologie und Neurophysiologie
- Mr. Dr. Thomas Wehrum
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address scientific-contact

start of 1:1-Block address contact scientific-contact
- Telephone: ++49-0761 270-50010
- Fax: [---]*
- E-mail: thomas.wehrum at uniklinik-freiburg.de
- URL: http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact scientific-contact
Contact for Public Queries
start of 1:1-Block address public-contact
- Universitätsklinikum FreiburgAbteilung Neurologie und Neurophysiologie
- Mr. Dr. Thomas Wehrum
- Breisacherstraße 64
- 79106 Freiburg
- Germany
end of 1:1-Block address public-contact

start of 1:1-Block address contact public-contact
- Telephone: ++49-0761 270-50010
- Fax: [---]*
- E-mail: thomas.wehrum at uniklinik-freiburg.de
- URL: http://www.uniklinik-freiburg.de/neurologie/forschung/neurologische-arbeitsgruppen/neurovaskulaere-bildgebung.html
end of 1:1-Block address contact public-contact

end of 1:n-Block addresses

start of 1:n-Block material support

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)
start of 1:1-Block address materialSupport
- Deutsche Forschungsgemeinschaft
- Kennedyallee 40
- 53175 Bonn
- Germany
end of 1:1-Block address materialSupport

start of 1:1-Block address contact materialSupport
- Telephone: [---]*
- Fax: [---]*
- E-mail: [---]*
- URL: http://www.dfg.de
end of 1:1-Block address contact materialSupport

end of 1:n-Block material support

start of 1:1-Block state

Status

Recruitment Status: Recruiting complete, follow-up complete
Study Closing (LPLV): 2015/01/31

end of 1:1-Block state

start of 1:n-Block publications

Trial Publications, Results and other Documents

[---]*

end of 1:n-Block publications

* This entry means the parameter is not applicable or has not been set.